To develop a computer-aided diagnosis (CAD) system for the classification of benign versus malignant findings on 18F-PSMA PET/CT imaging. It was applied in patients with biochemical recurrent (BCr) prostate cancer (PCa), using post-therapy follow-up (FU) imag...
Vasiliki Chatzipavlidou, MD, PhDAnna Makridou, PhDTheodoros Kalathas, MD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine